Skip to main content
Erschienen in: World Journal of Surgery 2/2012

01.02.2012

Adverse Outcomes in Patients with Postoperative Ascites after Liver Resection for Hepatocellular Carcinoma

verfasst von: Kun-Ming Chan, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Ming-Chin Yu, Wei-Chen Lee, Miin-Fu Chen

Erschienen in: World Journal of Surgery | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Postoperative ascites (POA) is a common complication after liver resection (LR). The aim of the present study was to identify the risk factors for developing POA and to evaluate its clinical significance in the prognosis of patients with hepatocellular carcinoma (HCC).

Methods

We performed a retrospective analysis of data obtained from 651 patients who underwent LR for the treatment of HCC between January 2001 and July 2005. The patients selected for the study were categorized and analyzed on the basis of the presence or absence of POA.

Results

Overall, 166 (25.5%) patients developed POA. A multivariate logistic regression analysis identified that five significant factors—cirrhotic liver, high indocyanine green retention, portal hypertension, hypoalbuminemia, and extent of LR—were associated with the development of POA. The recurrence-free survival and overall survival of patients with POA were significantly lower than those of patients without POA. The 5-year recurrence-free survival rates of patients with intractable POA over those of patients without POA were 31.7% versus 36.1%, and the corresponding 5-year overall survival rates were 17.4% versus 57.0%. The relative risk of mortality within 1 year in patients with POA was 2.4 times (95% confidence interval, 1.76–3.27; p < 0.001) higher than that in patients without POA.

Conclusions

A nomogram for predicting the probability of POA after LR for HCC was constructed on the basis of the identified risk factors, which may be used for risk-stratifying patients who may or may not benefit from surgical resection. Because patients with POA after LR show a high incidence of HCC recurrence and mortality risk, those with intractable ascites should be considered for prompt liver transplantation.
Literatur
1.
Zurück zum Zitat Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef
2.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406PubMedCrossRef Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406PubMedCrossRef
3.
Zurück zum Zitat Grazi GL, Ercolani G, Pierangeli F et al (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234:71–78PubMedCrossRef Grazi GL, Ercolani G, Pierangeli F et al (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234:71–78PubMedCrossRef
4.
Zurück zum Zitat Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–799PubMedCrossRef Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–799PubMedCrossRef
5.
Zurück zum Zitat Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195–198PubMedCrossRef Shimada M, Takenaka K, Fujiwara Y et al (1998) Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85:195–198PubMedCrossRef
6.
Zurück zum Zitat Wei AC, Tung-Ping PR, Fan ST et al (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90:33–41PubMedCrossRef Wei AC, Tung-Ping PR, Fan ST et al (2003) Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90:33–41PubMedCrossRef
7.
Zurück zum Zitat Salerno F, Borroni G, Moser P et al (1993) Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 88:514–519PubMed Salerno F, Borroni G, Moser P et al (1993) Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 88:514–519PubMed
8.
Zurück zum Zitat Rimola A, Garcia-Tsao G, Navasa M et al (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32:142–153PubMedCrossRef Rimola A, Garcia-Tsao G, Navasa M et al (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 32:142–153PubMedCrossRef
9.
Zurück zum Zitat Ikeda Y, Kanematsu T, Matsumata T et al (1993) Liver resection and intractable postoperative ascites. Hepatogastroenterology 40:14–16PubMed Ikeda Y, Kanematsu T, Matsumata T et al (1993) Liver resection and intractable postoperative ascites. Hepatogastroenterology 40:14–16PubMed
10.
Zurück zum Zitat Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51PubMedCrossRef Ishizawa T, Hasegawa K, Kokudo N et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51PubMedCrossRef
11.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430PubMedCrossRef
12.
13.
Zurück zum Zitat Makuuchi M, Sano K (2004) The surgical approach to HCC: our progress and results in Japan. Liver Transpl 10(2 Suppl 1):S46–S52 Makuuchi M, Sano K (2004) The surgical approach to HCC: our progress and results in Japan. Liver Transpl 10(2 Suppl 1):S46–S52
14.
Zurück zum Zitat Lee CF, Yu MC, Kuo LM et al (2007) Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J 30:333–338PubMed Lee CF, Yu MC, Kuo LM et al (2007) Using indocyanine green test to avoid post-hepatectomy liver dysfunction. Chang Gung Med J 30:333–338PubMed
15.
Zurück zum Zitat Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338PubMedCrossRef Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338PubMedCrossRef
16.
Zurück zum Zitat Moore KP, Wong F, Gines P et al (2003) The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38:258–266PubMedCrossRef Moore KP, Wong F, Gines P et al (2003) The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 38:258–266PubMedCrossRef
17.
Zurück zum Zitat Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364–1370PubMedCrossRef Iasonos A, Schrag D, Raj GV et al (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364–1370PubMedCrossRef
18.
Zurück zum Zitat Fausto N, Campbell JS, Riehle KJ (2006) Liver regeneration. Hepatology 43(2 Suppl 1):S45–S53 Fausto N, Campbell JS, Riehle KJ (2006) Liver regeneration. Hepatology 43(2 Suppl 1):S45–S53
19.
Zurück zum Zitat Gines P, Cardenas A, Arroyo V et al (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654PubMedCrossRef Gines P, Cardenas A, Arroyo V et al (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654PubMedCrossRef
20.
Zurück zum Zitat Yeh CN, Chen MF, Lee WC et al (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81:195–202PubMedCrossRef Yeh CN, Chen MF, Lee WC et al (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81:195–202PubMedCrossRef
21.
Zurück zum Zitat Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P et al (2001) A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 34:46–52PubMedCrossRef Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P et al (2001) A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 34:46–52PubMedCrossRef
22.
Zurück zum Zitat Heuman DM, Abou-Assi SG, Habib A et al (2004) Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40:802–810PubMed Heuman DM, Abou-Assi SG, Habib A et al (2004) Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 40:802–810PubMed
23.
Zurück zum Zitat Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403PubMedCrossRef Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403PubMedCrossRef
Metadaten
Titel
Adverse Outcomes in Patients with Postoperative Ascites after Liver Resection for Hepatocellular Carcinoma
verfasst von
Kun-Ming Chan
Chen-Fang Lee
Ting-Jung Wu
Hong-Shiue Chou
Ming-Chin Yu
Wei-Chen Lee
Miin-Fu Chen
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 2/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1367-1

Weitere Artikel der Ausgabe 2/2012

World Journal of Surgery 2/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.